ACADIA PHARMACEUTICALS INC — Director's Dealing 2017

Jul 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2017-07-17

Reporting Person: Daly James M (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-17	Stock Option (right to buy)	$28.85	A	15000	Acquired	2027-07-16	Common Stock (15000)	Direct

Footnotes

F1: 25% of the shares subject to the stock option vest and become exercisable at the end of each 3-month period following the date of ACADIA's 2017 Annual Meeting of Stockholders, or June 13, 2017.